JLL Partners related stories
All articles and analysis
- Slideshow: More LBO Targets In The CRO Market
The Carlyle Group and Hellman & Friedman's $3.9 billion agreement /120789/carlyle-hf-latest-shops-drawn-to-consolidating-cro-industry/ to buy Pharmaceutical Product Development Inc. marks the latest example of buyout shops buying companies that run clinical trials for pharma and biotech companies. These so-called contract research organizations, or CROs, are expected to expand http://finance.yahoo.com/news/CROs-Still-On-Sale-Industry-ms-546960507.html?x=0 and consolidate, making it highly likely we could see more LBOs. Click through below to see a selection of other noteworthy CROs, presented alphabetically, that could look attractive to sponsors. These include public companies that, like PPD, might find it easier to navigate the market's consolidation under private ownership; public companies with recent changes at the CEO level; and private equity-owned companies, including one that's been in its owner's portfolio for almost four years now.
- JLL Partners Sells C.H.I. Overhead to Friedman Fleischer
Friedman Fleischer & Lowe said Wednesday that it has completed its buy of C.H.I. Overhead Doors. Terms of the deal weren't disclosed. JLL Partners acquired the Arthur, Ill. garage door maker in the in fall of 2004. News of the C.H.I. sale was reported /113094/jll-partners-selling-chi-overhead-doors-after-nearly-7-years/ by The Deal in July.
- JLL Partners Selling C.H.I Overhead Doors After Nearly 7 Years
It looks like JLL Partners will be exiting C.H.I. Overhead Doors after nearly seven years. Friedman Fleischer & Lowe is buying C.H.I. Overhead https://www.lcdcomps.com/lcd/f/article.html?rid=800&aid=12330738 a garage door maker, according to Standard & Poor's LCD. Friedman Fleischer is in the market for a $203.5 million loan to back its by of C.H.I., LCD said. GE Capital and Wells Fargo are financing the deal, Thomson Reuters Loan Pricing Corp. said http://www.loanconnector.com/loanconnector/AcceptContract.do The Deal, which reported the C.H.I sale last week, said the transaction was valued at roughly $290 million http://www.thedeal.com/pdf/JLLCarey.pdf
- JLL Partners Exits PharmaNet
New York-based private equity shop JLL Partners has completed the sale of its portfolio company PharmaNet Development Group to inVentiv Health Inc. JLL acquired PharmaNet in 2009. inVentiv Health is an affiliate of Thomas H. Lee Partners. PharmaNet provides drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries.